Chronic Myelomonocytic Leukemia
Showing NaN - NaN of 12
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +14 more
- Azacitidine
- +2 more
-
Scottsdale, Arizona
- +233 more
Dec 8, 2016
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014
Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Polycythemia Vera Trial in Chicago (imatinib mesylate, laboratory
Completed
- Chronic Myelomonocytic Leukemia
- +3 more
- imatinib mesylate
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
Feb 24, 2014
